Xanthohumol

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Xanthohumol
DrugBank Accession Number
DB15359
Background

Xanthohumol is under investigation in clinical trial NCT01367431 (Xanthohumol and Metabolic Syndrome).

Type
Small Molecule
Groups
Investigational
Structure
Weight
Average: 354.3964
Monoisotopic: 354.146723814
Chemical Formula
C21H22O5
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
T4467YT1NT
CAS number
6754-58-1
InChI Key
ORXQGKIUCDPEAJ-YRNVUSSQSA-N
InChI
InChI=1S/C21H22O5/c1-13(2)4-10-16-18(24)12-19(26-3)20(21(16)25)17(23)11-7-14-5-8-15(22)9-6-14/h4-9,11-12,22,24-25H,10H2,1-3H3/b11-7+
IUPAC Name
(2E)-1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one
SMILES
COC1=C(C(=O)\C=C\C2=CC=C(O)C=C2)C(O)=C(CC=C(C)C)C(O)=C1

References

General References
Not Available
Human Metabolome Database
HMDB0037479
KEGG Compound
C16417
ChemSpider
555077
BindingDB
50384998
ChEBI
66331
ChEMBL
CHEMBL253896
ZINC
ZINC000005158937
Wikipedia
Xanthohumol

Clinical Trials

Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
PhaseStatusPurposeConditionsCount
2RecruitingTreatmentCrohn's Disease (CD)1
1Active Not RecruitingOtherHealthy Subjects (HS)1
1CompletedPreventionStress Oxidative1
0SuspendedTreatmentCoronavirus Disease 2019 (COVID‑19) / COVID-19 Respiratory Infection1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.00556 mg/mLALOGPS
logP3.91ALOGPS
logP5.2Chemaxon
logS-4.8ALOGPS
pKa (Strongest Acidic)7.01Chemaxon
pKa (Strongest Basic)-4.9Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count5Chemaxon
Hydrogen Donor Count3Chemaxon
Polar Surface Area86.99 Å2Chemaxon
Rotatable Bond Count6Chemaxon
Refractivity103.53 m3·mol-1Chemaxon
Polarizability38.52 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveNoChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-000l-3359000000-513a171f819b95432ac8
MS/MS Spectrum - ESI-TOF , NegativeLC-MS/MSsplash10-014i-0940000000-46dc70d70ca70dcf01b4
MS/MS Spectrum - ESI-TOF 20V, NegativeLC-MS/MSsplash10-014i-0940000000-46dc70d70ca70dcf01b4
MS/MS Spectrum - ESI-TOF , NegativeLC-MS/MSsplash10-0udi-0009000000-adffe3727a9d190af9ea
MS/MS Spectrum - ESI-TOF 20V, NegativeLC-MS/MSsplash10-0ue9-0159000000-89390bf396bc026f25db
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0udi-0029000000-5292b3ba1142d29c7386
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0ue9-0497000000-dec7e1db8ee3c405c5da
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0159-0981000000-c78fd55b14d98033f180
LC-MS/MS Spectrum - LC-ESI-TOF , negativeLC-MS/MSsplash10-0ue9-0159000000-89390bf396bc026f25db
MS/MS Spectrum - , negativeLC-MS/MSsplash10-0uxr-0978000000-bb0b197988e97a4a05ca
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-004j-0970000000-179d5086107c87523593
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-004i-0910000000-2dea6c7222209825ac37
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-004i-0900000000-4e1106c364aad0846401
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0002-0293000000-07b3d1d40f210eb9247b
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-004i-0940000000-6983981e47a0f6af296b
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-004i-0900000000-cee69c093feb8d9b8aa3
LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0002-0190000000-ec80f253f42d34e79be9
LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0002-0190000000-c3d920598c6526bdb0ba
LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0002-0290000000-a3b357466ef6c20fc37d
LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0002-0290000000-a6fb7803116d7827f288
MS/MS Spectrum - , positiveLC-MS/MSsplash10-004i-0900000000-20b63a44f7960299109b
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a71-0789000000-1859324778b1a1be180f
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0udi-0029000000-f886b147515bf9fce574
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0f8i-0296000000-5c04ee4e949535e2e3da
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0059-0953000000-2cc5999c021d050d770a
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-066r-0966000000-ef55cee34847d2072479
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-004i-0922000000-6754341d490227dc1d3d
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-214.1718077
predicted
DarkChem Lite v0.1.0
[M-H]-213.8085077
predicted
DarkChem Lite v0.1.0
[M-H]-190.71013
predicted
DeepCCS 1.0 (2019)
[M+H]+213.6946077
predicted
DarkChem Lite v0.1.0
[M+H]+213.2565077
predicted
DarkChem Lite v0.1.0
[M+H]+193.06813
predicted
DeepCCS 1.0 (2019)
[M+Na]+213.8108077
predicted
DarkChem Lite v0.1.0
[M+Na]+213.0725077
predicted
DarkChem Lite v0.1.0
[M+Na]+199.31021
predicted
DeepCCS 1.0 (2019)

Drug created at May 20, 2019 15:19 / Updated at June 12, 2020 16:53